Home › Funds › Arnhold LLC › REGN

Arnhold LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Arnhold LLC reported holding 6,228 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$4.7M, representing 0.34% of its reported portfolio and ranking #45 among its reported holdings. Arnhold LLC has disclosed REGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)6.23K sh
Reported value held$4.72M
Portfolio Weight0.34%
First reportedQ2 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Arnhold LLC's REGN position evolved

Arnhold LLC first disclosed a stake in REGN in Q2 2025 at 6,228 shares (US$3.3M). The position peaked in Q1 2026 at 6,228 shares, worth US$4.8M. Across 6 filings, Arnhold LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 6,228 shares valued at US$4.7M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 6.23K $3.27M New
Q3 2025 6.23K $3.50M Hold
Q4 2025 6.23K $4.81M Hold
Q1 2026 6.23K $4.81M Hold
Q2 2026 6.23K $3.88M Hold
Q3 2026 6.23K $4.72M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Arnhold LLC held REGN?

Arnhold LLC has disclosed REGN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Arnhold LLC's current position in REGN?

As of Q3 2026, Arnhold LLC holds 6.23K shares of REGN (REGENERON PHARMACEUTICALS), valued at $4.72M, representing 0.34% of its reported portfolio and ranking #45.

Has Arnhold LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), Arnhold LLC held unchanged its position in REGN. The position peaked in Q1 2026 at 6.23K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.